Serina Therapeutics, Inc. (AMEX:SER) Financings
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Tranche closed: US$6 a share · JonesTrading Institutional Services LLC Dealers: JonesTrading Institutional Services LLC (lead) | Nov 13, 2025 |
| Financing agreement tranche Tranche closed: US$5M raised · US$5.18 a share · Warrants at US$5.44 Buyers: Greg Bailey, MD (leads the up to $20 million financing) Insiders: Financing led by Serina Board Director Greg Bailey, MD Use of proceeds: Advance the planned registrational trial of SER-252 for advanced Parkinson's disease | Oct 6, 2025 |